ArticleTranslational lung cancer research2021

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit.

Yusuke Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.